OTC Pharmaceuticals - Asia

Asia

The OTC Pharmaceuticals market in Asia is projected to generate a revenue of €67.44bn in 2024.
This market is expected to experience an annual growth rate of 6.19% from 2024 to 2029 (CAGR 2024-2029).
The largest market within this market is Cold & Cough Remedies, which is estimated to have a market volume of €14.90bn in 2024.
When compared to other regions globally, the in the United States leads in terms of revenue, generating €38,250.00m in 2024.
In terms of per capita revenue, each person in Asia is expected to generate €14.84 in 2024.
Furthermore, online sales are projected to contribute 20.74% of the total revenue in the OTC Pharmaceuticals market by 2024.
In Asia, the OTC Pharmaceuticals market in Japan is experiencing a surge in demand for natural and herbal remedies.

Key regions: United States, China, Germany, Japan, Europe

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Marché

Région

Comparaison de régions

Monnaie

Analyst Opinion

The OTC Pharmaceuticals market in Asia is experiencing significant growth and development due to several factors.

Customer preferences: Customers in Asia have shown a growing preference for over-the-counter (OTC) pharmaceutical products. This is primarily driven by the convenience and accessibility that OTC products offer. Consumers appreciate the ability to purchase medications without a prescription, as it saves them time and allows them to self-diagnose and self-treat common ailments. Additionally, OTC products are often more affordable than prescription medications, making them an attractive option for cost-conscious consumers.

Trends in the market: One of the key trends in the OTC Pharmaceuticals market in Asia is the increasing demand for herbal and traditional medicines. Asian countries have a rich history of using natural remedies for various health conditions, and this trend has continued to gain momentum in recent years. Consumers are seeking out OTC products that are derived from natural sources and have fewer side effects. This has led to the introduction of a wide range of herbal and traditional medicine products in the market.Another trend in the market is the rising popularity of online sales channels. With the increasing penetration of smartphones and internet connectivity in Asia, consumers are increasingly turning to online platforms to purchase OTC pharmaceutical products. Online sales channels offer convenience, a wide range of product options, and competitive pricing. E-commerce platforms are also leveraging technology to provide personalized recommendations and information on product usage, further enhancing the customer experience.

Local special circumstances: Asia is a diverse region with varying healthcare systems and regulations. In some countries, such as Japan and South Korea, the OTC Pharmaceuticals market is highly regulated, with strict requirements for product safety and efficacy. This has led to a higher level of consumer trust in OTC products, as they are perceived to be of high quality. In contrast, other countries may have more relaxed regulations, leading to concerns about product quality and safety among consumers.

Underlying macroeconomic factors: The growing middle-class population in Asia is a key driver of the OTC Pharmaceuticals market. As disposable incomes rise, more consumers are able to afford healthcare products and are willing to spend on OTC medications. This has created a larger customer base for OTC pharmaceutical companies and has fueled market growth.Additionally, the aging population in Asia is contributing to the growth of the OTC Pharmaceuticals market. With increasing age, individuals are more likely to experience chronic health conditions and require regular medications. OTC products that cater to the needs of the elderly population, such as pain relievers and vitamins, are in high demand.Furthermore, the increasing prevalence of lifestyle-related diseases, such as diabetes and obesity, is driving the demand for OTC pharmaceutical products. As individuals become more health-conscious, they are seeking out OTC medications to manage and prevent these conditions. This trend is expected to continue as the awareness of preventive healthcare grows.In conclusion, the OTC Pharmaceuticals market in Asia is experiencing growth and development due to customer preferences for convenience and accessibility, the increasing demand for herbal and traditional medicines, the rising popularity of online sales channels, and underlying macroeconomic factors such as the growing middle-class population, the aging population, and the increasing prevalence of lifestyle-related diseases.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.